Navigation Links
Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine
Date:1/5/2011

he company employs innovative approaches to bring the right medicines to the right patients. There are currently more than 10 investigational compounds in development across a broad scientific platform, including cytotoxic, antimitotic, anti-angiogenic agents, antivascular agents as well as supportive care therapies. Three of these compounds are now being investigated in phase III clinical studies aimed at multiple solid and hematologic tumors.

About sanofi-aventisSanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients.  Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

For more information, www.sanofi-aventis.us or www.sanofi-aventis.com.

About BiPar SciencesBiPar Sciences is a biopharmaceutical organization dedicated to pioneering novel tumor-selective therapies designed to address urgent unmet needs of cancer patients. Located in South San Francisco, California, BiPar is a wholly-owned subsidiary of sanofi-aventis.  For more information, please visit www.biparsciences.com.

Forward-Looking StatementsThis press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended.  Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects," "anticipates," "believes," "
'/>"/>

SOURCE sanofi-aventis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
3. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
4. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
6. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
7. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
8. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
9. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
10. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
11. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 2, 2015 Intarcia Therapeutics, Inc. ... million from its recently announced synthetic royalty / equity ... million. Investors have purchased Convertible Limited Recourse Notes from ... to 2.0% of any future global net sales of ... paid. Investors also have the option, commencing upon U.S. ...
(Date:6/2/2015)... , June 2, 2015 Stoltenberg ... consulting firm, today announced the celebration of its ... throughout the U.S., since its inception in 1995. ... skillful workforce in the healthcare technology industry continues, ... a company-wide dedication to facilitating clients, organizational goals, ...
(Date:6/2/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... the development of oral drug delivery systems, announced today ... its orally ingestible insulin capsule on type 1 diabetic ... the ADA 75 th Scientific Sessions on June ... poster will be attended by Oramed,s Chief Scientific Officer, ...
Breaking Medicine Technology:Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 3Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 2Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 3Oramed to Present at the American Diabetes Association 75th Scientific Sessions 2Oramed to Present at the American Diabetes Association 75th Scientific Sessions 3Oramed to Present at the American Diabetes Association 75th Scientific Sessions 4
... Oct. 4, 2011 Argos Therapeutics, Inc. today announced that ... M.D., was awarded the Nobel Prize in medicine for the ... system. Dr. Steinman,s discovery of dendritic cells and ... dendritic cells in adaptive immunity have led to the development ...
... Oct. 4, 2011 Medical Alarm Concepts Holding, Inc. ... alarm system that allows the user to speak and ... is beta testing its next generation medical alarm, and ...  The new MediPendant™ will have enhanced features, including but ...
Cached Medicine Technology:Argos Therapeutics' Late Scientific Co-founder Ralph Steinman, M.D., Awarded Nobel Prize in Medicine for Discovery of Dendritic Cells as Critical Sentinels of Immune System 2Medical Alarm Concepts Announces Beta Testing of Next Generation MediPendant™ Medical Alarm Technology! 2Medical Alarm Concepts Announces Beta Testing of Next Generation MediPendant™ Medical Alarm Technology! 3
(Date:6/2/2015)... 2015 TMG Health, the leading national ... in the Medicare Advantage, Medicare Part D, and Managed ... exhibitor at AHIP’s Institute 2015, the annual meeting of ... conference will be held June 3-5 in Nashville, Tenn. ... opportunities for attendees to schedule private discussions with senior ...
(Date:6/2/2015)... 02, 2015 Milton Hershey School® graduate ... the 30 members of the Physician Assistant Program’s entering ... He was presented with a white coat, which symbolizes ... are extremely proud of Vincent’s accomplishments both at MHS ... a great example of how a top-notch education can ...
(Date:6/2/2015)... June 02, 2015 ANT Wireless, proven ... market entry of two new products implementing the ANT+ ... announce new wireless interoperability in their bike trainer products, ... cyclists. Tacx has implemented the FE-C device profile in ... well as its new indoor training software, while Kinomap ...
(Date:6/2/2015)... June 02, 2015 MAP Health Management, ... revenue cycle management for addiction treatment facilities, announced today ... President of Marketing. Mr. Smith will be responsible for ... awareness and visibility of MAP’s core message, products and ... the Marketing Manager at Cottonwood Financial in Irving, Texas, ...
(Date:6/2/2015)... DiaTech Oncology, provider of CorrectChemo®, the ... help oncologists provide personalized cancer treatment, has gained ... for its laboratories in the U.S. and Canada. ... the ‘Good Housekeeping’ seal of approval,” says Robert ... DiaTech. “It’s a rigorous inspection that confirms our ...
Breaking Medicine News(10 mins):Health News:TMG Health to Sponsor and Exhibit at AHIP’s Institute 2015 2Health News:First ANT FE-C Enabled Fitness Products Enter Market 2Health News:First ANT FE-C Enabled Fitness Products Enter Market 3Health News:Jared Smith Joins MAP Health Management, LLC, as Vice President of Marketing 2Health News:DiaTech Oncology Gains College of American Pathologists Accreditation for U.S. CorrectChemo Laboratory 2
... anthrax vaccine, used to combat bio-warfare, is to be restarted ... and South Korea, declared// the Pentagon on Monday. However it ... in other places including the US. ,The assistant secretary ... this is because the danger of infection is considered higher ...
... with some valuable information which would definitely help us ... of an autistic person is blue printed. ... affected by autism a developmental disorder typically characterized by ... ,Lead researcher Dr Michael Murias, from the University ...
... protected from certain food allergies by feeding them fermented milk//. ... as a weaning food. The researchers found that it has ... in allergic responses. ,The risk of food allergy ... the only remedy is not to give that particular food.,Consumption ...
... spread across Uttar Pradesh with 44 new cases, taking the ... up// in many areas Monday. ,Though the death toll ... cases since Saturday. The spread of the disease has been ... rise with 16 of the 37 samples examined at the ...
... complained of burning eyes and nausea in Madhya Pradesh ... which remains unknown//. ,"Around 200 people in Kirat ... and burning sensation in their eyes perhaps after inhaling ... Arun Kumar Bhatt told IANS by phone. ...
... they are serving meals that are unappetizing, tepid or downright ... trusts. ,The survey revealed that 40% of patients ... relatives and friends. Over 37% of patients reported leaving a ... a fifth of patients claimed that the hospital meals were ...
Cached Medicine News:Health News:500 People Affected by Gas Leak Near Bhopal 2Health News:NHS Food Slowing Patient Recovery 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: